Cardiac complications of unwitting co-injection of quinine/quinidine with heroin in an intravenous drug user.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3509315)

Published in J Gen Intern Med on May 17, 2012

Authors

Karran A Phillips1, Glenn A Hirsch, David H Epstein, Kenzie L Preston

Author Affiliations

1: National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 251 Bayview Blvd, Bldg BRC, Suite 200, Baltimore, MD 21224, USA. phillipsk@nida.nih.gov

Articles cited by this

Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther (2010) 2.17

Cardiotoxicity of antimalarial drugs. Lancet Infect Dis (2007) 2.15

Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med (1985) 2.12

Agranulocytosis associated with cocaine use - four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep (2009) 1.96

Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J Cardiovasc Pharmacol (1983) 1.49

Quinidine. N Engl J Med (1998) 1.03

Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol Lett (2000) 1.00

Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev (2010) 0.99

Necrosis of ears after use of cocaine probably adulterated with levamisole. Dermatology (2011) 0.97

Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal (2010) 0.94

A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Br J Clin Pharmacol (1993) 0.90

A descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine. J Toxicol Clin Toxicol (2000) 0.85

Safety of herbal supplements: a guide for cardiologists. Cardiovasc Ther (2010) 0.83

Estimating the risk of fatal arrhythmia in patients in methadone maintenance treatment for heroin addiction. Drug Alcohol Rev (2011) 0.82

Antiarrhythmic activity of quinine in humans. Circulation (1995) 0.82

Levamisole-induced lichenoid eruptions. J R Soc Med (1980) 0.79

Bogus heroin. J Emerg Nurs (1997) 0.79

Atypical reactions associated with heroin use--five states, January-April 2005. MMWR Morb Mortal Wkly Rep (2005) 0.79

Monitoring of intravenous quinidine infusion in the treatment of Plasmodium falciparum malaria. Ann Pharmacother (1995) 0.78

Detection and characterization of synthetic steroidal and non-steroidal anti-inflammatory drugs in Indian ayurvedic/herbal products using LC-MS/TOF. Drug Test Anal (2009) 0.78

Laboratory confirmation of scopolamine co-intoxication in patients using tainted heroin. J Toxicol Clin Toxicol (1999) 0.78

Articles by these authors

Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) (2006) 4.23

A memory retrieval-extinction procedure to prevent drug craving and relapse. Science (2012) 4.04

Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42

Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch Gen Psychiatry (2009) 2.95

Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol (2005) 2.32

Noninvasive visualization of coronary artery endothelial function in healthy subjects and in patients with coronary artery disease. J Am Coll Cardiol (2010) 2.09

Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging (2006) 2.06

Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav (2003) 1.94

The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers? Addict Behav (2002) 1.74

The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors. Neuropsychopharmacology (2005) 1.68

Cocaine craving and use during daily life. Psychopharmacology (Berl) (2009) 1.62

Tobacco, cocaine, and heroin: Craving and use during daily life. Addict Behav (2009) 1.56

Effects of stress on decision-making deficits in formerly heroin-dependent patients after different durations of abstinence. Am J Psychiatry (2011) 1.50

A meta-analysis of retention in methadone maintenance by dose and dosing strategy. Am J Drug Alcohol Abuse (2009) 1.49

The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking. Prog Neurobiol (2009) 1.48

Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther (2004) 1.46

Preliminary investigation of respiratory self-gating for free-breathing segmented cine MRI. Magn Reson Med (2005) 1.46

Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol Psychiatry (2011) 1.44

The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) (2003) 1.43

Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (Berl) (2011) 1.37

Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol (2006) 1.34

Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl) (2007) 1.32

Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addict Behav (2005) 1.31

A factor analysis of the Fagerström Test for Nicotine Dependence (FTND). Nicotine Tob Res (2003) 1.28

Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev (2006) 1.22

Daily life hour by hour, with and without cocaine: an ecological momentary assessment study. Psychopharmacology (Berl) (2010) 1.21

Are We There Yet? Feasibility of Continuous Stress Assessment via Wireless Physiological Sensors. ACM BCB (2015) 1.12

Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (Berl) (2011) 1.12

Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug Alcohol Depend (2008) 1.11

Gender and stimulus difference in cue-induced responses in abstinent heroin users. Pharmacol Biochem Behav (2007) 1.09

Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers. Pharmacol Biochem Behav (2007) 1.08

Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. Sci Transl Med (2013) 1.08

Heroin and cocaine craving and use during treatment: measurement validation and potential relationships. J Subst Abuse Treat (2006) 1.08

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend (2003) 1.08

Abstinence reinforcement maintenance contingency and one-year follow-up. Drug Alcohol Depend (2002) 1.06

Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin. J Consult Clin Psychol (2007) 1.06

Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry (2010) 1.05

The effect of methadone maintenance on illicit opioid use, human immunodeficiency virus and hepatitis C virus infection, health status, employment, and criminal activity among heroin abusers during 6 months of treatment in china. J Addict Med (2007) 1.02

Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase. Vasc Med (2003) 1.02

The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. Am Heart J (2006) 1.01

Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J Anal Toxicol (2002) 1.00

Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving. Psychopharmacology (Berl) (2009) 0.99

Puffing behavior during the smoking of a single cigarette in tobacco-dependent adolescents. Nicotine Tob Res (2009) 0.97

Marriage and relationship closeness as predictors of cocaine and heroin use. Addict Behav (2008) 0.96

A dose response study of cognitive behavioral therapy in cocaine abusers. J Subst Abuse Treat (2002) 0.95

Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course. Drug Alcohol Depend (2011) 0.95

Randomized trial comparing two treatment strategies using prize-based reinforcement of abstinence in cocaine and opiate users. J Appl Behav Anal (2008) 0.94

Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients. Addict Behav (2007) 0.94

Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. J Subst Abuse Treat (2007) 0.94

Nonreporting of cannabis use: Predictors and relationship to treatment outcome in methadone maintained patients. Addict Behav (2006) 0.93

Regional coronary endothelial function is closely related to local early coronary atherosclerosis in patients with mild coronary artery disease: pilot study. Circ Cardiovasc Imaging (2012) 0.92

Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-testing method. Drug Alcohol Depend (2007) 0.90

Adverse events among patients in a behavioral treatment trial for heroin and cocaine dependence: effects of age, race, and gender. Drug Alcohol Depend (2005) 0.90

Psychosocial stress after reactivation of drug-related memory impairs later recall in abstinent heroin addicts. Psychopharmacology (Berl) (2008) 0.90

Progression to daily smoking: is there a gender difference among cessation treatment seekers? Subst Use Misuse (2007) 0.89

EEG absolute power during extended cocaine abstinence. J Addict Med (2007) 0.89

Prognostic significance of cardiac troponin I levels in hospitalized patients presenting with supraventricular tachycardia. Medicine (Baltimore) (2010) 0.88

Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans. Exp Clin Psychopharmacol (2006) 0.87

Coronary artery distensibility assessed by 3.0 Tesla coronary magnetic resonance imaging in subjects with and without coronary artery disease. Am J Cardiol (2011) 0.87

Effect of reinforcement probability and prize size on cocaine and heroin abstinence in prize-based contingency management. J Appl Behav Anal (2008) 0.87

A meta-analysis of Chinese herbal medicine in treatment of managed withdrawal from heroin. Cell Mol Neurobiol (2008) 0.86

Effects of high-dose intravenous buprenorphine in experienced opioid abusers. J Clin Psychopharmacol (2004) 0.86

Recent marijuana blunt smoking impacts carbon monoxide as a measure of adolescent tobacco abstinence. Subst Use Misuse (2005) 0.86

Non-invasive detection of coronary endothelial response to sequential handgrip exercise in coronary artery disease patients and healthy adults. PLoS One (2013) 0.85

Hospitalists' ability to use hand-carried ultrasound for central venous pressure estimation after a brief training intervention: a pilot study. J Hosp Med (2013) 0.85

Polymorphisms of the beta adrenergic receptor predict left ventricular remodeling following acute myocardial infarction. Cardiovasc Drugs Ther (2011) 0.85

Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life. Drug Alcohol Depend (2013) 0.85

Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome. Drug Alcohol Depend (2008) 0.85

A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management. Drug Alcohol Depend (2012) 0.84

Heart failure with transient left bundle branch block in the setting of left coronary fistula. Cardiol Res Pract (2011) 0.84

Influence of psychotherapy attendance on buprenorphine treatment outcome. J Subst Abuse Treat (2005) 0.84

Circadian alteration in neurobiology during 30 days of abstinence in heroin users. Biol Psychiatry (2009) 0.84

Do noncontingent vouchers increase drug use? Exp Clin Psychopharmacol (2003) 0.83

Hemodynamic and cognitive effects of lofexidine and methadone coadministration: a pilot study. Pharmacotherapy (2007) 0.83

Methadone treatment induces attenuation of cerebrovascular deficits associated with the prolonged abuse of cocaine and heroin. Neuropsychopharmacology (2002) 0.83

A focus-group study on spirituality and substance-user treatment. Subst Use Misuse (2010) 0.83

TGI Monday?: drug-dependent outpatients report lower stress and more happiness at work than elsewhere. Am J Addict (2012) 0.82

Spiritual/Religious experiences and in-treatment outcome in an inner-city program for heroin and cocaine dependence. J Psychoactive Drugs (2007) 0.82

Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study. Pharmacotherapy (2009) 0.82